본문 바로가기
KERD
논문KCI 등재

Performance Characteristics of the UniCel DxI 800 Immunoassay for the Maternal Serum Quadruple Test, Including Median Values for Each Week of Gestation, in Korean Women

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

주제분류병리학

초록

Background : Maternal serum prenatal quadruple screening includes testing for alpha-fetoprotein (AFP), human chorionic gonadotrophin (hCG), unconjugated estriol (uE3), and dimeric inhibin A (DIA). We evaluated quadruple screening using an automated platform and looked for any ethnic differences in the median values of each marker. Methods : We measured the concentrations of each quadruple test analyte using the UniCel DxI 800 system (Beckman Coulter, USA) in 788 Korean mid-trimester maternal serum samples and calculated their median values using Benetech software (Benetech, Canada). We also compared the results with those obtained using the Immulite 2000 assay (Siemens Healthcare Diagnostics, USA) or ELISA (DSL, USA) in 442 samples. Results : We obtained mid-trimester median values for each marker. The following are the comparative results for each test using the Immulite 2000 assay or ELISA (x) and the UniCel DxI 800 immunoassay (y): AFP, y=1.10x+0.01, r=0.925; uE3, y=0.28x+0.24, r=0.885; hCG, y=1.22x-3047.8,r=0.944; and DIA, y=0.86x+15.31, r=0.833. Assay results for each of the four markers showed good correlations. However, significant biases necessitated new median calculations of prenatal risk estimates in all four tests. Conclusions : We established gestational age-specific second-trimester median values for four markers in Korean samples using the UniCel DxI 800 immunoassay system. Despite significant bias, there were good correlations between the results obtained using the UniCel DxI 800 immunoassay and those obtained using the Immulite 2000 assay. (Korean J Lab Med 2010;30:126-32)

Abstract

Background : Maternal serum prenatal quadruple screening includes testing for alpha-fetoprotein (AFP), human chorionic gonadotrophin (hCG), unconjugated estriol (uE3), and dimeric inhibin A (DIA). We evaluated quadruple screening using an automated platform and looked for any ethnic differences in the median values of each marker. Methods : We measured the concentrations of each quadruple test analyte using the UniCel DxI 800 system (Beckman Coulter, USA) in 788 Korean mid-trimester maternal serum samples and calculated their median values using Benetech software (Benetech, Canada). We also compared the results with those obtained using the Immulite 2000 assay (Siemens Healthcare Diagnostics, USA) or ELISA (DSL, USA) in 442 samples. Results : We obtained mid-trimester median values for each marker. The following are the comparative results for each test using the Immulite 2000 assay or ELISA (x) and the UniCel DxI 800 immunoassay (y): AFP, y=1.10x+0.01, r=0.925; uE3, y=0.28x+0.24, r=0.885; hCG, y=1.22x-3047.8,r=0.944; and DIA, y=0.86x+15.31, r=0.833. Assay results for each of the four markers showed good correlations. However, significant biases necessitated new median calculations of prenatal risk estimates in all four tests. Conclusions : We established gestational age-specific second-trimester median values for four markers in Korean samples using the UniCel DxI 800 immunoassay system. Despite significant bias, there were good correlations between the results obtained using the UniCel DxI 800 immunoassay and those obtained using the Immulite 2000 assay. (Korean J Lab Med 2010;30:126-32)

참고문헌 (21)

  1. Wald NJ, "Maternal serum screening for Down’s syndrome in early pregnancy", BMJ, 297, pp.883~887 (1988)
  2. Egan JF, "Antenatal Down syndrome screening in the United States in 2001: a survey of maternal-fetal medicine specialists", Am J Obstet Gynecol, 187, pp.1230~1234 (2002)
  3. 김지명, "삼중표지자 선별검사 양성 임산부의 양수 염색체 분석", The Korean Journal of Laboratory Medicine, 26(2), pp.123~130 (2006), 대한진단검사의학회
  4. Kim SK, "Triple marker screening for fetal chromosomal abnormalities in Korean women of advanced maternal age", Yonsei Med J, 42, pp.199~203 (2001)
  5. 한성희, "임신중기 양수천자 31,615예에 대한 임상 및 세포유전학적 결과", The Korean Journal of Laboratory Medicine, 28(5), pp.378~385 (2008), 대한진단검사의학회
  6. Benn PA, "Egan JF. Combined second-trimester biochemical and ultrasound screening for Down syndrome", Obstet Gynecol, 100, pp.1168~1176 (2002)
  7. Benn PA, "Incorporation of inhibin-A in second-trimester screening for Down syndrome", Obstet Gynecol, 101, pp.451~454 (2003)
  8. Wald NJ, "SURUSS in perspective", Semin Perinatol, 29, pp.225~235 (2005)
  9. Lambert-Messerlian GM, "Inhibin A measurement using an automated assay platform", Prenat Diagn, 28, pp.399~403 (2008)
  10. National Committee for Clinical Laboratory Standards, "Evaluation of precision performance of quantitative measurement methods:approved guideline. NCCLS document EP5-A2. 2nd ed" (2004), NCCLS
  11. Rawlins ML, "Performance characteristics of the Access Inhibin A assay", Clin Chim Acta, 397, pp.32~35 (2008)
  12. Erickson JA, "Evaluation of a dimeric inhibin-A assay for assessing fetal Down syndrome: establishment, comparison, and monitoring of median concentrations for normal pregnancies", Arch Pathol Lab Med, 128, pp.415~420 (2004)
  13. Vranken G, "Medians for second-trimester maternal serum markers: geographical differences and variation caused by median multiples-of-median equations", J Clin Pathol, 59, pp.639~644 (2006)
  14. Crandall BF, "Schroth PC, Matsumoto M. Alpha-fetoprotein concentrations in maternal serum: relation to race and body weight", Clin Chem, 29, pp.531~533 (1983)
  15. Bogart MH, "Prospective evaluation of maternal serum human chorionic gonadotropin levels in 3428 pregnancies", Am J Obstet Gynecol, 165, pp.663~667 (1991)
  16. Simpson JL, "Second trimester maternal serum human chorionic gonadotropin and unconjugated oestriol levels in blacks and whites", Lancet, 335, pp.1459~1460 (1990)
  17. Benn PA, "Medians for second-trimester maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol; differences between races or ethnic groups", Clin Chem, 43, pp.333~337 (1997)
  18. Benn PA, "Evaluation of effect of analytical imprecision in maternal serum screening for Down’s syndrome", Ann Clin Biochem, 38, pp.28~36 (2001)
  19. Serdar MA, "The effects of analytical factors on second trimester risk estimations", Int J Gynaecol Obstet, 93, pp.28~32 (2006)
  20. Wald NJ, "Validation plots in antenatal screening for Down’s syndrome", J Med Screen, 13, pp.166~171 (2006)
  21. 김솔잎, "국내 생화학적 표지자 산전선별검사 기초조사 보고", The Korean Journal of Laboratory Medicine, 27(1), pp.28~33 (2007), 대한진단검사의학회

이 간행물의 다른 논문 (15건)